Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Little Green Pharma Ltd. ( (AU:LGP) ) has provided an announcement.
Little Green Pharma Ltd reported a quarterly revenue of $9.1 million, marking a 20% increase compared to the previous year, with cash receipts reaching $12.0 million, up nearly 50%. The company has seen significant growth in its European market, particularly in Germany, where sales from its Danish facility have increased by over 70%. The company is expanding its capacity with new facilities and preparing for new laws that will allow its Danish site to act as a cannabis import, packing, and distribution hub starting January 2026.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is a company in the cannabis industry, focusing on the production and distribution of cannabis products. It operates facilities in Denmark and has a significant market presence in Europe, particularly in Germany.
Average Trading Volume: 107,691
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$33.44M
For an in-depth examination of LGP stock, go to TipRanks’ Overview page.